Pfizer earnings miss as breast cancer drug sales fall short
Pfizer’s earnings missed expectations, as sales of its breast cancer drug disappointed in the latest quarter. Yahoo Finance's Anjalee Khemlani joins Seana Smith on The Ticker to discuss.
Advertisement
Recommended Stories
Why Coca-Cola Consolidated Stock Skyrocketed Over $1,000 Per Share Today
You won't believe the amount of money that the bottler intends to return to shareholders.
Motley FoolAndreessen Horowitz partner says Google is an ‘amazing example’ of employing people in ‘BS jobs’: ‘Half the white-collar staff probably does no real work’
“Those people aren’t just being useless (and being coddled to think useless jobs actually matter—they don’t), but they are also taking money away from the rest of the workforce’s retirement programs.”
FortuneFormer Yahoo CEO Marissa Mayer was Google’s first female engineer—only because she tried to delete a recruiter email and accidentally opened it instead
Mayer's career can be boiled down to a single wrong keystroke.
FortuneBill Gates Harvests $113 Million In Nebraska Farmland, Takes Out $700 Million In Loans
Over the past six years, billionaire Bill Gates has spent more than $113 million purchasing Nebraska farmland and has taken out two loans totaling $700 million against it. Gates owns about 20,000 acres of farmland in Nebraska, where longtime friend and fellow billionaire Warren Buffett resides. The farmland is held by more than 20 shell companies. Why would one of the world's richest people need to take out a loan? Many high-net-worth individuals borrow against their assets if they need money th
BenzingaIf You'd Invested $10,000 in General Electric Stock 10 Years Ago, Here's How Much You'd Have Today
Prepare yourself for a big shock.
Motley FoolWarren Buffett's $56 Billion Silent Warning to Wall Street May Portend Trouble for Stocks
The Oracle of Omaha's short-term actions and long-term ethos don't always mesh.
Motley FoolSigns of the Top? Warren Buffett Selling His Biggest Holding
Warren Buffett is selling his largest holding, and that's a huge deal.
Motley Fool3M Cut Its Dividend: It's Time to Buy the Stock
The industrial giant has taken the right actions in cutting its dividend and clarifying its legal issues, and it is now fully in restructuring mode.
Motley FoolNvidia Targets 'Perfect' Breakout — And 473% Growth
Featuring Nvidia, Cava, Chipotle and more, this stock screener highlights top-rated stocks to buy and watch right now.
Investor's Business DailyCitigroup Recommends 3 Stocks to Buy — Including One With 77% Upside Potential
After a rocky month of April, investor sentiment has improved somewhat. At least in part, this can be attributed to a better-than-expected earnings season. So far, about 80% of the S&P 500-listed companies have reported their Q1 results, and 77% of those have shown a quarterly EPS above the forecasts. Overall, the earnings reported are 7.5% better than the estimates, a beat that’s well above the 6.7% decadal average. Scott Chronert, a U.S. equity strategist at Citigroup, comments on the broader
TipRanks